Geron (GERN) Price to Sales (2010 - 2026)
Geron's (GERN) quarterly Price to Sales came in at 14.31 in Q2 2026, down 22.01% year-over-year from 18.35 in Q2 2025, and down 22.21% quarter-over-quarter from 18.39 in Q1 2026.
Analysis
Geron (GERN) Price to Sales (2010 - 2026) Analysis & Trends
Geron has disclosed Price to Sales across 17 years of filings, most recently posting 14.31 for Q2 2026.
- In Q2 2026, Price to Sales fell 22.01% year-over-year to 14.31; the TTM figure through Jun 2026 stood at 3.37 (down 33.68% YoY), while the FY2025 annual figure was 3.79, down 84.23% from the prior year.
- Price to Sales came in at 14.31 for Q2 2026 at Geron, down from 18.39 in the prior quarter.
- In the past five years, Price to Sales ranged from a high of 57931.72 in Q2 2023 to a low of 9.68 in Q4 2025.
- Average Price to Sales over 5 years is 11192.04, with a median of 2950.73 recorded in 2022.
- Year-over-year, Price to Sales jumped 2314.48% in 2022 and plunged 99.93% in 2024.
- Over 5 years, Price to Sales stood at 9169.28 in 2022, then soared by 445.19% to 49989.77 in 2023, then tumbled by 99.93% to 35.8 in 2024, then sank by 72.96% to 9.68 in 2025, then soared by 47.79% to 14.31 in 2026.
- Per Business Quant data, the three most recent Price to Sales figures were 14.31 in Q2 2026, 18.39 in Q1 2026, and 9.68 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.31 |
| Mar 31, 2026 | 18.39 |
| Dec 31, 2025 | 9.68 |
| Sep 30, 2025 | 18.52 |
| Jun 30, 2025 | 18.35 |
| Mar 31, 2025 | 25.57 |
| Dec 31, 2024 | 35.80 |
| Sep 30, 2024 | 97.08 |
| Jun 30, 2024 | 2,897.79 |
| Mar 31, 2024 | 6,438.61 |
| Dec 31, 2023 | 49,989.77 |
| Sep 30, 2023 | 7,020.09 |
| Jun 30, 2023 | 57,931.72 |
| Mar 31, 2023 | 52,572.58 |
| Dec 31, 2022 | 9,169.28 |
| Sep 30, 2022 | 3,003.67 |
| Jun 30, 2022 | 8,022.18 |
| Mar 31, 2022 | 4,173.40 |
| Dec 31, 2021 | 379.76 |
| Sep 30, 2021 | 4,046.52 |